Patents by Inventor Geena Malhotra

Geena Malhotra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200214593
    Abstract: A flow-sensing arrangement within a spirometer. The arrangement includes a tubular-member for allowing an air-passage along a longitudinal-axis thereof. At-least two disc-shaped air-resistive elements are removably-arranged within the tubular member to resist the air-flow. Each of the resistive-elements include perforations for allowing the air-passage through the resistive-element. At-least two ports extend radially outward through a wall of the tubular member, such that each of the two ports are located within the tubular-member near the resistive-elements to cause determination of at least a pressure-difference there-between.
    Type: Application
    Filed: July 26, 2018
    Publication date: July 9, 2020
    Inventors: Nandan KULKARNI, Vidur MALHOTRA, Geena MALHOTRA, Brinder AHLUWALIA
  • Publication number: 20200170983
    Abstract: Methods of treating bladder cancer using adapalene are disclosed herein. Adapalene can be administered as part of a comprehensive treatment program, which can also include chemotherapy, immunotherapy, radiation therapy and/or surgical treatment.
    Type: Application
    Filed: October 22, 2018
    Publication date: June 4, 2020
    Inventors: Geena Malhotra, Kalpana Joshi
  • Publication number: 20200155557
    Abstract: The present invention is concerned with the treatment of Pulmonary Arterial Hypertension (PAH) by administering Paliperidone. The instant invention further relates to use of a pharmaceutical composition comprising Paliperidone, for the treatment of PAH.
    Type: Application
    Filed: January 22, 2020
    Publication date: May 21, 2020
    Inventors: Karl Roberts, Geena Malhotra, Dhiraj Abhyankar, Kalpana Joshi, Jeevan Ghosalkar
  • Publication number: 20200147328
    Abstract: A breath-actuated inhaler includes a motion-generator configured to render motion upon actuation by a user. An arrangement transforms the generated motion to enable a canister at undergoing translation-motion. A metering-valve is operably connected to the canister to cause a metered-release of the canister's contents as a spray, based upon the translation-motion.
    Type: Application
    Filed: July 11, 2018
    Publication date: May 14, 2020
    Inventors: Nandan KULKARNI, Vidur MALHOTRA, Geena MALHOTRA, Brinder AHLUWALIA, Mohnish Jagdish ZAVERI
  • Publication number: 20200131211
    Abstract: The present invention relates to certain acid salts of (((1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)(phenoxy) phosphoryloxy)methyl pivalate of Formula (I), to processes for their preparation; to pharmaceutical compositions comprising such compounds, and methods of treating a disease which responds to inhibition of nucleotide reverse transcriptase activity.
    Type: Application
    Filed: March 16, 2018
    Publication date: April 30, 2020
    Inventors: Manjinder Singh PHULL, Ashwini Amol SAWANT, Dharmaraj Ramachandra RAO, Geena MALHOTRA, Manish Gopaldas GANGRADE
  • Publication number: 20200113919
    Abstract: The invention relates to pharmaceutical compositions comprising ((((((R)-1-(6-amino-9H-purin-9-yl) propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)oxy)methyl pivalate or a pharmaceutically acceptable derivative thereof, optionally with an additional agent, methods of making them, and their use in medicine.
    Type: Application
    Filed: June 29, 2018
    Publication date: April 16, 2020
    Inventors: Geena MALHOTRA, Kalpana JOSHI, Jeevan GHOSALKAR, Atul DAROI, Siddharth AGRAWAL
  • Patent number: 10576083
    Abstract: The present invention is concerned with the treatment of Pulmonary Arterial Hypertension (PAH) by administering Paliperidone. The instant invention further relates to use of a pharmaceutical composition comprising Paliperidone, for the treatment of PAH.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: March 3, 2020
    Assignee: Cipla (UK) Limited
    Inventors: Karl Roberts, Geena Malhotra, Dhiraj Abhyankar, Kalpana Joshi, Jeevan Ghosalkar
  • Publication number: 20200046688
    Abstract: A pharmaceutical composition is provided for the treatment of systemic infections as well as colonic diseases. The composition comprises a therapeutically effective amount of rifaximin and a therapeutically effective amount of at least one alkaloid or derivative thereof. Methods and kits are also provided.
    Type: Application
    Filed: October 13, 2017
    Publication date: February 13, 2020
    Applicant: Cipla Limited
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • Publication number: 20200046701
    Abstract: A pharmaceutical composition is provided comprising coy combination of antiretroviral drugs optionally in combination of pharmacokinetic boosters. The formulation is used for the treatment of diseases caused by retroviruses. The process of preparation of the formulation is also provided.
    Type: Application
    Filed: April 18, 2018
    Publication date: February 13, 2020
    Inventors: Geena MALHOTRA, Kalpana JOSHI, Preeti RAUT
  • Publication number: 20200046721
    Abstract: Disclosed herein are methods of treating cancers by administration of a PAR-4 agonist.
    Type: Application
    Filed: May 23, 2019
    Publication date: February 13, 2020
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • Patent number: 10500185
    Abstract: Disclosed herein are improved formulations for the cabazitaxel. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: December 10, 2019
    Assignee: Cipla Limited
    Inventors: Geena Malhotra, Sarabjit Singh, Ravichandra Bhadravathi Vedamurthy, Anirban Mallik Thakur, Dhiraj Abhyankar
  • Patent number: 10493079
    Abstract: Disclosed herein are stabilized formulations of carfilzomib. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: December 3, 2019
    Assignee: Cipla Limited
    Inventors: Harshad Kishore Shete, Pankaj Omprakash Pathak, Sarabjit Singh, Geena Malhotra
  • Publication number: 20190350844
    Abstract: A pharmaceutical long acting depot composition is provided as an aid to smoking cessation treatment. The formulation comprises a therapeutically effective amount of varenicline or its pharmaceutically acceptable derivative and pharmaceutically acceptable excipients. The process of preparation of the formulation is also provided.
    Type: Application
    Filed: May 15, 2019
    Publication date: November 21, 2019
    Inventors: Geena MALHOTRA, Sarabjit SINGH
  • Patent number: 10471048
    Abstract: The present invention relates to methods of treatment of hepatitis C using prasugrel. The methods of the present invention can be used in patients with hepatitis C administering prasugrel in combination with one or more anti-hepatitis C drugs.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: November 12, 2019
    Assignee: Cipla Limited
    Inventors: Karl Roberts, Geena Malhotra, Dhiraj Abhyankar, Kalpana Joshi, Jeevan Ghosalkar
  • Patent number: 10420727
    Abstract: A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: September 24, 2019
    Assignee: Cipla Limited
    Inventors: Geena Malhotra, Shrinivas Purandare
  • Publication number: 20190270735
    Abstract: The present invention provides novel polymorphic forms of dasatinib compound of the formula 1 as well as the process for the preparation thereof.
    Type: Application
    Filed: October 30, 2017
    Publication date: September 5, 2019
    Inventors: Dharmaraj Ramachandra RAO, Geena MALHOTRA, Srinivas Laxminarayan PATHI, Ravikumar PUPPALA, Yellanki JAGANNADHAM, Ramanaiah CHENNURU
  • Patent number: 10391080
    Abstract: Methods of treating cancer, including PAR-4 implicated cancers or renal cell carcinoma, using ketorolac are disclosed herein. Ketorolac can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: August 27, 2019
    Assignee: Cipla Limited
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • Publication number: 20190247389
    Abstract: Methods of treating bladder cancer using terconazole are disclosed herein. Terconazole can be administered as part of a comprehensive treatment program, which can also include chemotherapy, immunotherapy, radiation therapy and/or surgical treatment.
    Type: Application
    Filed: November 6, 2018
    Publication date: August 15, 2019
    Inventors: Geena Malhotra, Kalpana Joshi
  • Publication number: 20190231801
    Abstract: Disclosed herein are methods of treating ovarian cancer comprising administering to a subject in need thereof an effective amount of methacycline, or a pharmaceutically acceptable salt thereof. The methacycline can be administered as part of treatment regimen, which also can include other chemo- or immune-therapies, radiation therapy, and/or surgical treatments.
    Type: Application
    Filed: October 1, 2018
    Publication date: August 1, 2019
    Inventors: Geena Malhotra, Kalpana Joshi
  • Publication number: 20190224204
    Abstract: This invention relates to novel pharmaceutical formulations of Bruton's tyrosine kinase (BTK) inhibitor Ibrutinib. This invention also relates to methods of using the Ibrutinib pharmaceutical formulations, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, cancers, including lymphoma, and inflammatory diseases or conditions.
    Type: Application
    Filed: August 19, 2017
    Publication date: July 25, 2019
    Inventors: Geena Malhotra, Jinesh Chauhan, Kishore Kothule, Ravichandra Bhadravathi Vedamurthy, Anirban Mallik Thakur